GCTK
GlucoTrack, Inc.
$0.80
-6.93%
2026-05-08
About GlucoTrack, Inc.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Key Fundamentals
EPS (TTM)
$-31.22
Profit Margin
0.0%
Debt/Equity
121.85
Price/Book
0.27
Beta
0.77
Market Cap
$3.0M
Avg Volume (10D)
21.1M
Recent Breakout Signals
No recent breakout signals detected for GCTK.
Recent Price Range (60 Days)
60D High
$1.75
60D Low
$0.62
Avg Volume
4.5M
Latest Close
$0.80
Get breakout alerts for GCTK
Sign up for Breakout Scanner to receive daily notifications when GCTK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
GlucoTrack, Inc. (GCTK) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors GCTK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. GCTK operates in the Healthcare sector within the Medical Instruments & Supplies industry. Data is provided for informational purposes only and does not constitute financial advice.